Cargando…
Advances in Clinical Oncology Research on (99m)Tc-3PRGD2 SPECT Imaging
The integrin alpha(α)v beta(β)3 receptor is ubiquitous in malignant tumors and has a certain level of specificity for tumors. Technetium-99m hydrazinonicotinamide-dimeric cyclic arginyl-glycyl-aspartic acid peptide with three polyethylene glycol spacers ((99m)Tc-3PRGD(2)) can bind specifically to th...
Autores principales: | Xiao, Liming, Xin, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195171/ https://www.ncbi.nlm.nih.gov/pubmed/35712468 http://dx.doi.org/10.3389/fonc.2022.898764 |
Ejemplares similares
-
Direct attenuation correction for (99m)Tc-3PRGD(2) chest SPECT lung cancer images using deep learning
por: Xing, Haiqun, et al.
Publicado: (2023) -
(99m)Tc-3PRGD(2) SPECT/CT Imaging for Diagnosing Lymph Node Metastasis of Primary Malignant Lung Tumors
por: Xiao, Liming, et al.
Publicado: (2023) -
Evaluation of
(99m)Tc‐3PRGD(2) SPECT imaging on angiogenesis in animal models of lung cancer
por: Wu, Yongkun, et al.
Publicado: (2022) -
(99m)Tc-3PRGD(2) SPECT Predicts the Outcome of Endostar and Cisplatin Therapy in Xenograft Animals
por: Sun, Wei, et al.
Publicado: (2019) -
Scintigraphic Imaging of Neovascularization With
(99m)Tc-3PRGD(2) for Evaluating Early Response to Endostar
Involved Therapies on Pancreatic Cancer Xenografts In Vivo
por: Jin, Xiaona, et al.
Publicado: (2021)